In his latest videos, Neil Woodford responds to critics and defends his investment strategy. Is his latest poor performance just a blip?
The big names of fund management – Smith, Woodford, Lindsell and Train – lead the most-bought list once again.
Neil Woodford has issued an apology for his fund’s poor performance – offering up an explanation to his investors.
The latest FTSE 100 review has seen the Royal Mail pushed out, while Berkley Group has returned after last year’s Brexit relegation.
Star fund manager Neil Woodford is nursing huge losses after a spectacular profits warning.
Woodford Patient Capital’s performance has picked up over the last three months and Woodford is optimistic it will continue.
There are two new entries into our table of most-bought trusts, while Woodford Patient Capital has slipped out of the top three.
Half of our top 10 in July were passive funds, while Smith, Lindsell and Train lead the pack once again.
Fund manager Neil Woodford has been selling down exposure to tobacco, a sector that he has invested in for the majority of his career. He explains why.
Following a trip to the AGM, Richard Beddard outlines the investment case for Woodford Patient Capital trust.